Sigma Healthcare Ltd ( (AU:SIG) ) has issued an announcement.
Sigma Healthcare Limited operates as a major pharmacy wholesaler and retail healthcare group in Australia, with its merged operations now anchored around the Chemist Warehouse network. The company focuses on pharmaceutical distribution, retail pharmacy services and related health products, positioning the enlarged group as a scale player in the national pharmacy and consumer health market.
The merger with Chemist Warehouse, completed via scheme of arrangement in February 2025, has been treated as a reverse acquisition for accounting purposes, with Chemist Warehouse deemed the acquirer. Post-transaction, Sigma’s reporting has been aligned to Chemist Warehouse’s 30 June year-end under ASIC relief and ASX confirmations, providing a unified financial calendar for the merged group’s disclosures.
For the year to 30 June 2026, Sigma reported the first full-year results of the merged group, with sales revenue rising 80.5% to $10.83 billion and net profit after tax increasing 34.9% to $708.7 million versus the prior comparative period. Net tangible asset backing per share improved 43.5% to 9.9 cents, reflecting a stronger balance sheet following integration of the Chemist Warehouse business.
The board declared a fully franked final dividend of 2.0 cents per share for the 2026 financial year, matching the interim payout and exceeding the prior year’s final dividend of 1.3 cents. The company has no dividend reinvestment plan in place, and the audited results, signed off without modification by PwC, underline the merged group’s enhanced earnings scale and capacity to return cash to shareholders.
This story was written using TipRanks’s AI tools and reviewed by a TipRanks editor.
Leave a comment